Fundz

Bristol Myers Squibb partners with Hengrui Pharma for a multi-billion dollar collaboration to develop new drugs.

May 15, 2026

Contract Type

partnership

LawrencevilleManufacturingBiotechnologyProfessional ServicesHealth CareMedicalTherapeuticsPharmaceuticalLegalBiopharmaLaw Enforcement

Description

This week, Bristol Myers Squibb announced a significant partnership with Chinese drugmaker Hengrui Pharma to develop and test new drugs. The partnership aims to enhance drug development processes by conducting early-stage clinical trials in China, potentially leading to faster market introductions for new treatments.

Company Information

Company

Bristol Myers Squibb

Location

Lawrenceville, New Jersey, United States

About

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Related People

Cari
Likely contact at this company
••••••••@••••••••

See Cari's verified email →

Fernando
Senior decision-maker at this company
••••••••@••••••••

See Fernando's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Bristol Myers Squibb's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Bristol Myers Squibb signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.